PTC Signs Evrysdi Royalty Deal With Royalty Pharma For Up To $1.5 Bln; Stock Up In Premarket
PTC Therapeutics, Inc. (PTCT) announced Thursday an agreement with Royalty Pharma plc. (RPRX) to monetize up to $1.5 billion of the Evrysdi royalty stream. Under the deal, PTC will get … Read More